Pancreatic Cancer Research

ResearcherSecond Military Medical UniversityActive in the last 2 years

Duowu Zou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2461-5304; OpenAlex author ID A5047451275, A5091710771. Sources: ClinicalTrials.gov.

Their work

Papers
10 (first author 0, last author 4)
Trials
2 (principal investigator on 2)
Grants
0
Labs led
1
Collaborators
25
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: 2 papers · 2021: 2 trials · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 4 papers

Papers 10

  1. Single-Cell Analysis of Chemotherapy-induced Remodeling Reveals CD276-driven Basal-like Chemoresistance in Pancreatic Cancer. Co-author DOI 10.1053/j.gastro.2025.09.043↗
  2. Establishing a single-cell RNA sequencing workflow using EUS-guided fine-needle aspiration for pancreatic ductal adenocarcinoma. Last author DOI 10.1097/eus.0000000000000214↗
  3. Differentiating cytology of pancreatic ductal adenocarcinoma and pancreatic neuroendocrine tumors by EUS-FNA through hyperspectral imaging technology combined … Last author DOI 10.1177/17562848251414188↗
  4. Single-cell RNA sequencing reveals pancreatic cancer microenvironment heterogeneity for precision therapy. Last author DOI 10.1515/jtim-2026-0013↗
  5. PLXDC1+ Tumor-Associated Pancreatic Stellate Cells Promote Desmoplastic and Immunosuppressive Niche in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1002/advs.202415756↗
  6. A deep learning model using hyperspectral image for EUS-FNA cytology diagnosis in pancreatic ductal adenocarcinoma. Last author DOI 10.1002/cam4.6335↗
  7. Nicotine promotes tumor progression and epithelial-mesenchymal transition by regulating the miR-155-5p/NDFIP1 axis in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.pan.2020.04.004↗
  8. A nicotine-induced positive feedback loop between HIF1A and YAP1 contributes to epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s13046-020-01689-6↗
  9. Cigarette Smoking and Mortality in Patients With Pancreatic Cancer: A Systematic Review and Meta-analysis. Co-author DOI 10.1097/mpa.0000000000001383↗
  10. Incidence of pancreatic cancer in chinese patients with chronic pancreatitis. Co-author DOI 10.1159/000322982↗

Trials 2

  1. Clinical and Multiomics Study of First-line Chemotherapy for Advanced Pancreatic Cancer Principal investigator NCT05168254↗
  2. Influence Factors of PD-1 Therapeutic Efficacy in Advanced Pancreatic Cancer Principal investigator NCT05201729↗

Closest collaborators

The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tingting Gong · 2 shared papers, 2026 · strength 0.52
  2. Youqiong Ye · 2 shared papers, 2025–2026 · strength 0.45
  3. Yanhua Du · 2 shared papers, 2025–2026 · strength 0.45
  4. Chenghao Shao · 2 shared papers, 2025–2026 · strength 0.45
  5. Yaya Bai · 1 shared paper, 2026 · strength 0.43
  6. Xianzheng Qin · 2 shared papers, 2023–2026 · strength 0.39
  7. Yunwei Sun · 3 shared papers, 2019–2020 · strength 0.37
  8. Qiwen Ben · 3 shared papers, 2019–2020 · strength 0.37
  9. Yaozong Yuan · 3 shared papers, 2019–2020 · strength 0.37
  10. Yao Zhang · 1 shared paper, 2026 · strength 0.28
  11. Yao Zhang · 1 shared paper, 2026 · strength 0.23
  12. Ju‐Dong Li · 1 shared paper, 2025 · strength 0.22
  13. Hamid Alinejad‐Rokny · 1 shared paper, 2025 · strength 0.22
  14. Ting‐Ting Gong · 1 shared paper, 2023 · strength 0.15
  15. Yan Wang · 1 shared paper, 2023 · strength 0.15
  16. Wei An · 1 shared paper, 2020 · strength 0.13
  17. Lifu Wang · 1 shared paper, 2019 · strength 0.11
  18. Liang‐Hao Hu · 1 shared paper, 2011 · strength 0.02
  19. Jie Chen · 1 shared paper, 2011 · strength 0.02
  20. Luo‐Wei Wang · 1 shared paper, 2011 · strength 0.02
  21. Zhendong Jin · 1 shared paper, 2011 · strength 0.02
  22. Xianbao Zhan · 1 shared paper, 2011 · strength 0.02
  23. Zhaoshen Li · 1 shared paper, 2011 · strength 0.02
  24. Wei Wang · 1 shared paper, 2011 · strength 0.02
  25. Zhuan Liao · 1 shared paper, 2011 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.